antiplasmodial, 6) anticancer 7, 8) and PDE 4 inhibitory 9) activities. Aryloxypropanolamines were reported to be associated with b-adrenergic blocking, 10, 11) CNS depressant 12) and hypotensive 13) activities. In view of this potential nature of these moieties, it was thought worthwhile to study the effects of two pharmacophoric moieties such as quinoline and propanolamines/aminoethane in a single molecule. We have already reported the potential anticonvulsant activity and the b-blocking activity of propanolamine, aminopropane and aminoethane from our laboratory. [14] [15] [16] [17] [18] [19] [20] To explore the heteroaryl and propanolamine/aminoethane combination, it was envisaged that chemical entities with both quinoline and aryloxypropanolamine/aminoethane moieties would result in compounds with interesting biological activities.
In the present study, we report the synthesis, the anticonvulsant and antihypertensive activities, and the structureactivity relationship of 2-(3Ј-substituted-2Ј-hydroxy-propyloxy/2Ј-substituted-ethanoxy)-quinoline. The compounds were characterized by IR, 1 H-NMR spectral and elemental analysis. The compounds were investigated for anticonvulsant and antihypertensive activities. 1 H-NMR and IR spectra were consistent with the assigned structures. Synthesis of 8-(2-Chloroethanoxy)quinoline 8-Hydroxy quinoline was reacted with 1,2-dichloroethane, as reported by us earlier. 15) A mixture of 8-hydroxy quinoline (0.13 mol), 1,2-dichloro ethane (0.167 mol) and anhydrous potassium carbonate (0.195 mol) was refluxed in dry acetone (420 ml) for 40 h. The reaction mixture was filtered, and the filtrate on concentration yielded the product. The product was filtered, dried under vacuum and recrystallized by using chloroform-ether (1 : 1). Yieldϭ52%, mp 68-70°C. General Method of Synthesis for 1 to 12 A mixture of 8-(2Ј-chloroethanoxy)quinoline (0.01 mol), amine (0.012 mol), anhydrous sodium carbonate (0.007 mol) and sodium iodide (0.0034 mol) was refluxed in dry acetone (40 ml) for 65 h. The reaction mixture was filtered, and the filtrate on concentration yielded the product. The product was filtered, dried under vacuum and recrystallized using 1 : 1 acetone-diethyl ether (3, 5, 8), 1 : 1 ethanol-diethyl ether (1, 6, 9, 11), 1 : 1 chloroform-diethyl ether (7, 10) General Method of Synthesis for 13 to 20 A mixture of 8-(2Ј,3Ј-epoxypropyloxy)quinoline (0.01 mol), amine (0.012 mol), anhydrous sodium carbonate (0.007 mol) and sodium iodide (0.0034 mol) was refluxed in dry acetone (40 ml) for 65 h. The reaction mixture was filtered, and the filtrate on concentration yielded the product. The product was filtered, dried under vacuum and recrystallized using 1 : 1 acetone-diethyl ether (13, 17) 
PHARMACOLOGY
The experiments were carried out on Wistar albino mice (18-25 g) and Wistar rats (180-250 g). The animals were kept in colony cages at 25Ϯ2°C, relative humidity 45-55% under a 12 h light and dark cycle. All the animals were acclimatized for a week before use. The animals had free access to standard pellet diet and water. Control and experimental groups consisted of 6-8 animals each. The protection offered by the synthesized compounds against clonic and tonic convulsions in Wistar albino mice was screened at the dose levels of 30, 100 and 300 mg kg
Ϫ1
. Antihypertensive activity of the compounds was determined in normotensive anesthetized rats.
Anticonvulsant Activity The compounds were tested for anticonvulsant activity using the procedures described previously. 21, 22) All compounds were tested for anticonvulsant activity with Wistar albino mice. Each compound was administered intraperitoneally at three dose levels (30, 100, 300 mg kg
). The compounds were made into a solution with water for injection.
Maximal electroshock seizures (MES) were induced 30 min after drug treatment by application of a 50 mA current for 0.2 s via corneal electrodes into the eyes. The protection was defined as the abolition of the hind leg and tonic maximal extension component of the seizure. The subcutaneous pentylenetetrazole (Metrozol) seizure threshold test (sc-Met) was carried out by the subcutaneous administration of pentylenetetrazole (85 mg kg Ϫ1 ). Animals were observed for over 30 min. Failure to observe the generalized clonic seizure is defined as protection.
Minimal neurotoxicity (TD 50 ) was measured by the rotarod test (Tox). Mice were placed in 1-in. diameter knurled plastic rod rotating 6 rpm after administration of the drug, and their ability to maintain their balance was tested. Neurological deficit was indicated by the inability of the animal to maintain equilibrium for 1 min on the rotating rod in each of three trials. The results are tabulated in Tables 1 and 2 .
Antihypertensive Activity 23) Male Wistar normotensive rats were anesthetized with thiopental (50-75 mg kg
) by intraperitoneal injection. The right carotid artery was cannulated with a polyethylene tube filled with heparin in saline to facilitate pressure measurements using a Datamax apparatus. The studied compounds were injected in doses corresponding to IV into the caudal vein, after a 5 min stabilization period in a volume equivalent to 1 ml kg
. In a separate series of experiments on anesthetized nor- ) was investigated. Pressor responses of adrenaline, noradrenaline and isoprenaline injected intravenously were obtained before and at 5 min after administration of the test compounds. Results are presented in Table 4 .
RESULTS AND DISCUSSION
The initial evaluation (phase I) of anticonvulsant activity of synthesized compounds is presented in Table 1 . The compounds were administered intraperitoneally at three doses (30, 100, 300 mg kg Ϫ1 ). Three tests were performed for each compound: maximal electroshock (MES) induced convulsions, subcutaneous Metrozol (sc-Met) induced convulsions and the rotarod neurotoxicity test (Tox).
As a result of preliminary screening, compounds 2, 10, 11, 12, 13, 14, 17, 19 and 20 were considered for the phase II trials. This provides an evaluation of the median effective dose (ED 50 ) and median neurotoxic dose (TD 50 ). The slope of the regression line and the SE of the slope were then calculated. These data are shown in Table 2 . Some of these derivatives showed a high degree of protection against MES-induced seizures. But they were found to be less effective against scMet-induced seizures. ) were compared favorably with phenytoin.
The following structure-activity relationships were observed. In the ethane series (1-12), compounds 2, 10, 11 and 12 were found to have a high degree of protection against MES-induced seizures. Among the heterocyclic substituted compounds, the piperazino and imidazole substitution at the 2Ј position showed more protection than the other substitutions. Unsubstituted piperazine showed more protection than the substituted piperazines. The increase in the carbon atom number at the 4th position of piperazine influenced the activity remarkably. In the propanol series (12) (13) (14) (15) (16) (17) (18) (19) (20) , only compounds 13, 14, 19 and 20 were found to have a high degree of protection against MES-induced convulsions. 4-phenylpiperazino substituted compounds at the 3Ј position showed higher protection than the other substitutions at piperazine compounds. As with the ethane series compounds, an increase in the carbon atom at the 4th position of the nitrogen of the piperazine greatly influenced the anticonvulsant activity. 1686 Vol. 27, No. 10 b-Blockers and aryloxypropanolamines 24) inhibit adenylyl cyclase, which reduces the production of c-AMP (adenosine monophosphate). c-AMP activates the phosphorylation of a hydroxyl group containing amino acids such as tyrosine, serine and threonine, which causes the enzyme to change its shape, which then causes the release of Ca 2ϩ . Since b-blockers reduce c-AMP, fewer Ca 2ϩ ions are released. The propanol series of compounds may be correlated to the presence of a pharmacophore similarity to the chemical functionality present in b-adrenergic blocking agents. It may be hypothesized that the anticonvulsant activity exerted by some of the compounds is caused by blocking Ca 2ϩ channels. Calcium influx via voltage-activated Ca 2ϩ channels also plays a role in epileptogenesis and neurodegenerative events, raising the possibility that the blockade of Ca 2ϩ channels may represent the mechanism of action of these compounds.
13, 14, 18, 19 and 20 exhibited potential hypotensive activity. None of the ethane series compounds were found to be active. Among the propanol series, 4-substituted piperazino compound showed better hypotensive activity than the other heterocyclic compounds, whereas all other compounds were less active than the 4-substituted piperazino compound. Among the 4-substituted piperazino compounds, the methyl and ethyl substituted compounds were more active than the unsubstituted piperazino and phenyl compounds.
To examine the mechanism of the hypotensive effects of these compounds (13, 14, 18, 19, 20) , we studied their influence on the pressor responses to adrenaline, noradrenaline and isoprenaline (Table 4) The data were the means of 5-6 experiments S.E.M. a) Dose (100 mg kg
Ϫ1
). b) The difference between adrenaline induced an increase in BP and test compound induced a decrease in BP. c) The difference between noradrenaline induced an increase in BP and test compound induced a decrease in BP. d) The difference between isoprenaline induced an increase in BP and the test compound induced fall in BP.
